Su Xun X - OmicsDI

Show results for

Unknown (13)
Proteomics (4)
Metabolomics (1)

Organisms

Homo sapiens (2)
Candida albicans CAS15 (1)
Drosophila melanogaster (1)

Repository

iProX (2)
jPOST (2)
MetaboLights (1)

Technology Type

Mass spectrometry assay (1)

Instrument Platform

Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - positive - hilic (1)

Publication Date

2022 (2)
2021 (2)
2025 (1)

Metabolite Name

(+)-6-aminopenicillanic acid (1)
(+-)12-HETE (1)
(-)-catechin gallate (1)
(1-(5-fluoropentyl)-1h-indazole-3-carbonyl)-l-valine (1)
(1-acetyloxy-3-hydroxy-6,8a-dimethyl-7-oxo-3-propan-2-yl-2,3a,4,8-tetrahydro-1h-azulen-4-yl) 4-hydroxybenzoate (1)
(19r)-9-acetyl-19-hydroxy-10,14-dimethyl-20-oxopentacyclo[11.8.0.0<2,10>.0<4,9 >.0<14,19>]henicos-17-yl acetate (1)
(1e,4e)-1,5-bis(4-methoxyphenyl)penta-1,4-dien-3-one (1)
(2-aminoethoxy)[2-[docosa-4.7.10.13.16.19-hexaenoyloxy]-3-[hexadec-1-en-1-yloxy]propoxy]phosphinic acid (1)
(2-aminoethoxy)[2-[docosa-4.7.10.13.16.19-hexaenoyloxy]-3-[octadeca-1.9-dien-1-yloxy]propoxy]phosphinic acid (1)
(2-aminoethoxy)[3-[hexadec-1-en-1-yloxy]-2-(hexadecanoyloxy)propoxy]phosphinic acid (1)
(2-aminoethoxy)[3-[hexadec-1-en-1-yloxy]-2-[icosa-5.8.11.14-tetraenoyloxy]propoxy]phosphinic acid (1)
(2e,6e,10e)-13-[(2r)-6-hydroxy-2,8-dimethyl-3,4-dihydrochromen-2-yl]-2,6,10-trimethyltrideca-2,6,10-trienoic acid (1)
(2s,3r,5r,10r,13r,14s,17s)-2,3,14-trihydroxy-10,13-dimethyl-17-[(2r,3r,5r)-2,3,6-trihydroxy-5,6-dimethylheptan-2-yl]-2,3,4,5,9,11,12,15,16,17-decahydro-1h-cyclopenta[a]phenanthren-6-one (1)
(3s,4r)-7-hydroxy-3-[(3s,4r)-7-hydroxy-4-(4-hydroxyphenyl)-2-oxo-5-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydrochromen-3-yl]-4-(4-hydroxyphenyl)-5-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydrochromen-2-one (1)
(4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid (1)
(4e,8e)-10-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1h-2-benzofuran-5-yl)-4,8-dimethyldeca-4,8-dienoic acid (1)
(5e)-3,4,9-trihydroxy-2-propyl-2,3,4,7,8,9-hexahydrooxecin-10-one (1)
(9e)-11a-hydroxy-3,6,10-trimethyl-6,7,8,11-tetrahydro-4h-cyclodeca[b]furan-2,5-dione (1)
(S)-2-Hydroxyglutarate (1)
(n-(-2-acetamido))-2-aminoethanesulfonic acid (1)
(r)-butaprost (free acid) (1)
.alpha.-d-galactose 1-phosphate (1)
.beta.-hydroxypropionic acid (1)
.beta.-muricholic acid (1)
.gamma.-glutamyl-(s)-allyl-l-cysteine (1)
1,2-Distearoyl-sn-glycerol 3-phosphate (1)
1,2-dihydro-1,2-naphthalenediol (1)
1,2-dilauroyl-sn-glycero-3-phospho-sn-glycerol (1)
1,2-dimyristoyl-sn-glycero-3-phosphate (1)
1,2-dioleoyl-sn-glycero-3-phosphate (1)

Release Date

2025 (4)
2018 (2)
2024 (1)
2023 (1)
2022 (1)
2021 (1)
2019 (1)
2017 (1)
2016 (1)

Previous page
1 / 2
You're on page 1
page 2
Next page

Sort by:

Relevance

Page size

CAFs exosomal circFOXO1 promotes TNBC autophagy and radioresistance via miR-27a-3p/BNIP3 axis

Not available

S-EPMC12336314 | biostudies-literature

Systematic review and bayesian network meta-analysis: comparative efficacy and safety of six commonly used biologic therapies for moderate-to-severe Crohn's disease.

Not available

S-EPMC11794990 | biostudies-literature

TTC7A-ALK, a novel ALK fusion variant identified in a patient with metastatic lung adenocarcinoma, exhibits excellent response to crizotinib.

Not available

S-EPMC11930134 | biostudies-literature

Discovery of JND3229 as a New EGFR^C797S Mutant Inhibitor with In Vivo Monodrug Efficacy.

Not available

S-EPMC6231186 | biostudies-literature

Effect of Intermittent versus Chronic Calorie Restriction on Tumor Incidence: A Systematic Review and Meta-Analysis of Animal Studies.

Not available

S-EPMC5031958 | biostudies-literature

Surface charge controlled nucleoli selective staining with nanoscale carbon dots.

Not available

S-EPMC6544201 | biostudies-literature

Specialized metabolites present in <i>Camellia reticulata</i> nectar inhibit the growth of nectar-inhabiting microorganisms.

Not available

S-EPMC11913856 | biostudies-literature

Reconstruction of the tumor spatial microenvironment along the malignant-boundary-nonmalignant axis.

Not available

S-EPMC9941488 | biostudies-literature

Multi-kingdom gut microbiota dysbiosis is associated with the development of pulmonary arterial hypertension

Gut microbiota dysbiosis has been implicated in pulmonary arterial hypertension (PAH). However, most studies have focused on the bacterial community and the exact role and mechanisms of multi-kingdom gut microbiota, including bacteria, archaea and fungi in PAH remains largely unclear. Idiopathic ...

2025-05-12 | MTBLS10563 | MetaboLights

PBRM1-deficient PBAF complexes target de novo genomic loci to activate pro-survival genes in clear cell renal cell carcinoma (BRG1 dataset)

PBRM1 is lost in 40% of clear cell renal cell carcinomas (ccRCC) and the combined loss of VHL and PBRM1 drives ccRCC tumorigenesis. PBRM1 is an accessory subunit of the PBAF subclass of the SWI/SNF chromatin remodeler and despite its well-established role as a tumor suppressor, we have limited under...

ORGANISM(S): Homo Sapiens (human)

2021-07-24 | PXD020553 | JPOST Repository

Previous page
1 / 2
You're on page 1
page 2
Next page

Sort by:

Relevance

Page size

18 Results

Show results for

Organisms

Repository

Technology Type

Instrument Platform

Publication Date

Metabolite Name

Release Date

OmicsDI is part of the ELIXIR infrastructure

Tweets